The mutations of GJB2, SLC26A4, and mtDNA12SrRNA are the most common inherited causes of nonsyndromic sensorineural hearing loss (NSHL) in China, yet previous genetic screenings were mainly carried on patients with moderate-to-profound impairment. We aimed to detect the mutation frequencies in NSHL population within a more specified range of severity. Patients with profound NSHL who had undergone cochlear implantation in the Shandong Provincial Hospital (Shandong, China) were recruited. The majority (n = 472) were between 0.7 and 6 years old, and the remaining (n = 63) were between 6 and 70 years old. In total, 115 mutation alleles of the three genes were screened with SNP scan assay. Of the patients, 19.44% (104/535) were found to have GJB2 mutations, and the most common allele was c.235delC, followed by c.299_300delAT and c.109G>A. SLC26A4 mutations were detected in 13.46% patients (72/535), and the most common allele was c.919-2A>G (IVS7-2A>G), followed by c.1174A>T and c.2168A>G. Seven patients (1.31%) carried mutations in mtDNA12SrRNA, with the alleles of m.1555A>G and m.1494C>T. We found the allele frequency of c.109G>A (GJB2) was relatively lower in the profound NSHL population in comparison to the moderate-to-profound ones, and the c.1174A>T (SLC26A4) relatively higher. It suggests those mutations may be connected with the degree of deafness, which needs more observations and analyses to support.
Introduction
Hearing loss is the most common sensory disorder, affecting about 1-3 newborns in every 1,000 live births (Kral & O'Donoghue, 2010; Schimmenti et al., 2011) . In China, there are about 0.8 million children younger than 7 years of age whose hearing was disabled, and this number continues to grow with an increase of more than 30,000 deaf children annually. The prevalence of permanent sensorineural hearing loss continues to increase during childhood and reaches a rate of about 2.7 per 1,000 children before the age of 5 years and 3.5 per 1,000 during adolescence (Morton & Nance, 2006) .
The different clinical types of hearing loss include conductive hearing loss resulting from abnormalities of the external ear and/or the ossicles of the middle ear, sensorineural hearing loss resulting from malfunction of inner ear structures (i.e., cochlea) and/or dysfunction in the central auditory system (e.g., the eighth cranial nerve, auditory brain stem, or cerebral cortex), and mixed hearing loss (combination of conductive and sensorineural hearing loss). The sensorineural hearing loss can be divided into nonsyndromic hearing loss (NSHL) and syndromic hearing loss according to whether other organ systems are abnormal or not. While in terms of the degree, the hearing loss can be categorized into mild (26-40 dB), moderate (41-60 dB), severe (61-80 dB), and profound (>81 dB). The infants with profound hearing loss can encounter permanent hearing impairment with significant and irreversible defects in linguistic and cognitive development, if not detected and treated within the first postnatal year. However, this condition can be improved if identified and positively intervened before 6 months of age. Cochlear implantation can help patients with profound hearing loss to rehabilitate their aural abilities, which implants an electronic medical device that sends sound signals to the brain, displacing the work of the damaged inner ear.
Hearing loss is etiologically heterogeneous. It is estimated that at least two thirds of cases of childhood-onset hearing loss have genetic causes, and the majority (around 70%) of the inheritable hearing disorders are NSHL, involving mutations in many genes (Dai et al., 2008b Yuan et al., 2009) . NSHL may be transmitted as an autosomal recessive (80%), autosomal dominant (15-20%), X-linked trait (1%), or mitochondrial deafness (<1%) (Toriello & Smith, 2013) . In China, many previous genetic screening studies have shown that GJB2, SLC26A4, and mtDNA12SrRNA are the three most common causes of NSHL, accounting for 26.65-35.7% of NSHL in Chinese patients (Guo et al., 2008; Yuan et al., 2009; Xin et al., 2013) . Mutations in GJB2 have been reported to be the most common molecular defect in the Chinese deaf population (21%); of these mutations, c.235delC is the most common mutation allele ). The most common mutation of SLC26A4 seen in the Chinese deaf population is c.919-2A>G (IVS7-2A>G); its reported detection rate can be as high as 12.5% (Dai et al., 2008a,b; Yuan et al., 2012) . The most common mutation of mtDNA12SrRNA is m.A1555>G, and its detection rate is reported to be 3.43% in the Chinese deaf population (Liu et al., 2006) , and the m.1494C>T mutation is another prevalent mutation allele of mtDNA12SrRNA in the Chinese population (Zhang et al., 2013) .
GJB2 (Gap junction protein, beta-2) is the most prevalent gene, the mutations of which would result in NSHL Tsukada et al., 2010) . The protein plays a key role in recycling potassium ions (K+) of cochlea endolymph through intercellular communication, and it is vital for the auditory signal transduction and the achievement of auditory function in the organ of Corti of the inner ear (Spicer & Schulte, 1998; Apps et al., 2007) . When GJB2 is abnormal, it can prevent recycling of K+ ions after sound stimulation and that elevated K+ in the extracellular perilymph inhibited uptake of the neurotransmitter glutamate, which ultimately resulted in cell death within the hair cell population (CohenSalmon et al., 2002) . To date, more than 100 GJB2 mutations have been reported, most of which are found in patients with moderate-to-profound hearing loss (Tsukada et al., 2010) .
The second most prevalent gene whose mutations may cause NSHL is SLC26A4 (solute carrier family 26 member 4). It is located on chromosome 7 (7q31) and encodes a pendrin protein, and this protein is expressed in the thyroid, inner ear, and kidney. In the cochlea, pendrin was abundant in the apical membrane of cells in the spiral prominence and outer sulcus cells (along with their root processes) (Royaux et al., 2003) . The pendrin protein is a member of the solute carrier 26 family that involves in exchanging anions (chloride, iodide, bicarbonate, and formate). In the organ of Corti of the cochlea, pendrin is essential for transporting chloride-iodide and regulating the ionic homeostasis of endolymph. Mutations in the SLC26A4 gene may disrupt the ionic homeostasis of cochlea and lead to hearing loss. Until now, more than 200 mutations have been reported in the SLC26A4 gene.
Mutations in mitochondrial DNA (mtDNA) are also common molecular causes of deafness after that in GJB2 and SLC26A4. Individuals with mtDNA12SrRNA mutations are aminoglycoside-sensitive and may suffer late-onset hearing loss after inadvertent exposure to this drug .
China is a large country with the highest population in the world. Chinese people from different areas may have different genetic backgrounds due to geographical and language separation (Chen et al., 2009) . Although GJB2, SLC26A4, and mtDNA12SrRNA are the most common candidates in deafness-causing gene screenings, characterization of these gene defects in deafness patients from Shandong Province, especially patients with profound NSHL, have not yet been studied. Hence, the present study aimed to investigate the prevalence of the mutations in these three deafness-causing genes among patients (the majority were the deaf children under 6 years old) with profound NSHL, who had cochlear implantation in Shandong Province. The results of this study are expected to provide great help in cochlear preoperative evaluation and family counseling programs.
Materials and Methods

Patients and DNA Samples
The protocol of this investigation was approved by the Ethics Committee of Shandong University. The written informed consent was obtained from all the participants; in the case of minors, consent was obtained from their parents/guardians on their behalf. All of the subjects or their guardians signed the informed consent forms prior to blood sampling. Questionnaires consisted of basic information, including name, age, address, family history, health records of the mother during pregnancy, and a clinical history of the patient, such as infections, possible head or brain injury, and the use of aminoglycoside antibiotics.
A total of 564 NSHL patients who had undergone cochlear implantation from September 2012 to December 2015 in the Provincial Hospital Affiliated to Shandong University, Shandong Province, China, were recruited consecutively. All patients underwent hearing tests and medical examinations for the diagnosis of profound NSHL before cochlear implantation. Routine ear examination, otoscopy, and high-resolution CT scanning or MRI scanning on temporal bone were all performed to exclude disorders involving external ear or middle ear. The diagnostic criteria of profound NSHL were as follows: the auditory brainstem response threshold should be >90 dB, binaural tympanogram results indicating type A for both ears, and binaural distortion product otoacoustic emission results were negative for both ears.
There were 29 patients excluded from the analysis due to data missing. In other words, 535 patients actually participated in the study, from whom 2 mL peripheral blood was collected. Genomic DNA was extracted from peripheral blood samples using Axy Prep Genomic Blood DNA Extraction Kit (AXY-GEN, Union City, CA, USA). For the evaluation of the quantity and quality of extracted DNA, spectrophotometry (UNICO 2100, Dayton, NJ, USA), and 1% agarose gel electrophoresis were carried out according to routine methods (Bai et al., 2014) .
SNP Scan for Mutation Detection
Two customized multiplex SNP scan assays (one is 53-plex and the other is 62-plex) from Gene Sky Biotechnologies Inc. (Shanghai, China) were performed to capture a total of 115 mutation alleles of the deafness-causing genes GJB2, SLC26A4, and mtDNA12SrRNA, as previously described (Du et al., 2014) .
Statistical Analysis
The data were analyzed using SAS 9.1.3 software (SAS, Cary, NC), and the chi-squared test was used to make comparisons between results from different studies. A P-value of <0.05 was considered to be statistically significant.
Results
Demographic Data
Among the 535 participants, 307 patients were male and 228 were female. The majority of the patients (n = 472) were aged between 0.7 and 6 years old, the average age was 3.29 years, and remaining patients (n = 63) were between 6 and 70 years old, the average age was 12.79 years. As for ethnic groups, 530 patients were Han people and 5 were Hui people.
GJB2
A total of 15 variants were identified in this cohort, all of which had been reported in previous studies ( The mutant alleles of GJB2 accounted for 16.9% (181/1070) of the total alleles in the 535 profound NSHL patients. The most common mutation allele of GJB2 was c.235delC. The allele frequency of c.235delC was 10.09% (108/1070), followed by 2.52% (27/1070) for c.299_300delAT, 1.12% (12/1070) for c.109G>A, 0.65% (7/1070) for c.257C>G, 0.56% (6/1070) for c.511_512insAACG, 0.37% (4/1070) for c.176_191del16, 0.28% (3/1070) for c.34_35insG, c.605ins46, and c.427C>T, 0.19% (2/1070) for c.571T>C and c.9G>A; and 0.09% (1/1070) for each of the others.
The detection rate of GJB2 mutation carriers in the patients was 19.44% (104/535) ( Table 2 ). There were 14.39% patients (77/535) possessing mutations in both alleles of GJB2: 36 homozygotes (33 with c.235delC and 3 with c.299_300delAT) and 41 compound heterozygotes. In addition, 5.05% patients (27/535) carried only one mutation: 12 with c.235delC, 11 with c.109G>A, 2 with c.299_300delAT, and 2 with c. 571T>C. As the most common mutation of GJB2 detected in this cohort, c.235delC alleles were carried by 75 patients, including 33 homozygotes, 11 compound heterozygotes with c.299_300delAT, 2 compound heterozygotes with c.9G>A, 2 compound heterozygotes with c.176_191del16, 6 compound heterozygotes with c.257C>G, 1 compound heterozygote with c.427C>T, 1 compound heterozygote with c.283G>A, 1 compound heterozygote with c.598G>A, 1 compound heterozygote with c.605ins46, 1 compound heterozygote with c.34_35insG, 1 compound heterozygote with c.232G>A, 3 compound heterozygotes with c.511_512insAACG, and 12 single heterozygotes.
SLC26A4
A total of 25 variants were identified in this cohort, all of which had been reported in previous studies (Table 3) The mutant alleles of SLC26A4 accounted for 12.34% (132/1070) of the total alleles in the 535 NSHL patients. The most common mutation allele of SLC26A4 was c.919-2A>G, with the frequency of 6.92% (74/1070), followed by 0.93% (10/1070) for c.1174A>T and 0.75% (8/1070) for c.2168A>G.
The detection rate of SLC26A4 mutation carriers in the patients was 13.46% (72/535) ( Table 4 ). There were 11.78% patients (63/535) possessing mutations in both alleles of SLC26A4: 25 homozygotes (22 with c.919-2A>G, 1 with c.1174A>T, 1 with c.1226G>A, and 1 with c.589G>A) and 38 compound heterozygotes. In addition, 1.68% patients (9/535) carried only one mutation: three with c.919-2A>G, two with c.2027T>A, one with c.147C>G, one with c.235C>T, one with c.1174A>T, and one with c.2167C>G. As the most common mutation of SLC26A4 detected in this cohort, c.919-2A>G alleles were carried by 55 patients, including 22 homozygotes, 30 compound heterozygotes, and 3 single heterozygotes.
mtDNA12SrRNA
A total of two variants were identified in this cohort, all of which had been reported in previous studies. They were m.1555A>G with a frequency of 1.12% (6/535) and m.1494C>T with a frequency of 0.18% (1/535).
Discussion
GJB2, SLC26A4, and mtDNA12SrRNA are three of the most common disease-causing genes reported in Chinese NSHL population (Duan et al., 2015; Fang et al., 2015) . In this study, we used SNP scan assay to screen for the common deafness gene mutations among 535 profound NSHL patients who had undergone cochlear implantation in Shandong Province, East China.
In our study cohort, a total of 104 patients (19.44%) were found to possess GJB2 mutations, with 77 patients (14.39%) having mutations in both alleles and 27 patients (5.05%) with only one mutant allele. The most common mutation allele of GJB2 was c.235delC (10.09%), followed by c.299_300delAT (2.52%) and c.109G>A (1.12%). SLC26A4 mutations were detected in a total of 72 patients (13.46%), with 63 patients (11.78%) having mutations in both alleles and 9 patients (1.68%) with only one mutant allele. The most common mutation allele of SLC26A4 was c.919-2A>G (6.92%), followed by c.1174A>T (0.93%), and c.2168A>G (0.75%). In addition, seven patients (1.31%) carried mutations in mtDNA12SrRNA.
In congenital deafness, most pathogenic mutations were mapped to GJB2. This gene was first cloned in 1993 as the coding gene of connexin 26. The connexin 26 protein channel plays an important role in the exchange of substance and information transfer between cells (Apps et al., 2007) . Mutations in the coding region of the GJB2 gene can cause function defect or nonfunction of the connexin 26 protein, which further damage integrity of connection channel between epithelial cells and then lead to abnormal switch (Zheng et al., 2005 ). An abnormal switch can hinder information transfer, influence backflow of K+ into endolymph (leading to potassium intoxication), and then affect physiological activity of cochlear hair cell, causing sensorineural deafness (Spicer & Schulte, 1998) . GJB2 may also affect information transfer of Ca and inositol triphosphate (Oguchi et al., 2005) and then affect normal physiological function of auditory system. Many large-scale epidemiological investigations of the GJB2 gene mutation in deaf patients were performed in many countries. It was found that 46% of congenital deafness in NSHL patients were caused by the GJB2 gene mutation in Hungary, 24.3% in America, 11.5-22% in Brazil, and 12.2-33% in China Dai et al., 2015) . In the present study, it was also found that 19.44% of NSHL may be attributed to GJB2 gene mutations, which again suggested that the GJB2 gene mutation plays an important role in causing hereditary NSHL.
The specificities of the GJB2 gene mutation are varied between different races or ethnic populations (Snoeckx et al., 2005) . Yu et al. (2007) suggested that c.235delC, c.299_300delAT, and c. 176_191del16 were the common mutation types. In East and Southeast Asia, c.235delC has been reported as the most common mutation that acts as a frameshift mutation causing premature protein termination in hearing impaired patients, while lower frequencies were reported in Europe (Choi et al., 2009; Jiang et al., 2015) . In the East Asian deaf population, the c.109G>A mutation has been found to be common too, with 4.3% in Thailand (Wattanasirichaigoon et al., 2004) , 0.6% in Korea , and 1.0% in Japan (Abe et al., 2000) . In an earlier nationwide study conducted by Dai et al. (2009) , wherein the GJB2 gene mutations of 2,063 unrelated moderate-toprofound NSHL students from 23 different regions of China were analyzed, the top-ranking c.235delC frequency was reported as 12.34%, and 2.38% for c. 299_300delAT as well as 4.82% for c.109G>A. While in a more recent mutation screening performed on 339 moderate-to-profound NSHL children from Linyi (a city of Shandong Province, East China) (Zhang & Xiao, 2016) , which is a relatively conservative area due to its desolate geographical condition, c.235delC at a frequency of 20.65% was reported as the most frequent mutation of the GJB2 gene, followed by c.109G>A, which had a frequency of 2.51%. In addition, Li et al. reported that the c.109G>A in newborns was 6.2% (187/3032) in Shanghai, East China (Li et al., 2012) . In our present study, the top mutation allele was c.235delC, with a frequency of 10.09%, which was consistent with the nationwide study ) (P-value 2-tail = 0.05) but significantly different from data collected in the city of Linyi (Zhang & Xiao, 2016 ) (P-value 2-tail <0.001). Owing to the lower degree of openness in Linyi compared with the whole province of Shandong, we think that cochlear-implanted patients recruited in our study may be a more representative sample of the nationwide NSHL population. It seems that there may not be a bias in the c.235delC frequency among varying severity of the disease. Similar conclusions could be drawn upon the c.299_300delAT frequency (2.52%), since no markedly differences were found between our study and the nationwide study ) (P-value 2-tail = 0.87). Notably, for c.109G>A mutation allele (1.12%) screened in our work, there were remarkable differences appearing when compared with the study concerning newborns in Shanghai (Li et al., 2012 ) (P-value 2-tail < 0.001) and with the nationwide study encompassing moderate-to-profound NSHL population ) (P-value 2-tail < 0.001). There seemed to be a downward tendency of c.109G>A frequency when the average severity of hearing loss in the detected population was increasing. It echoed the idea proposed in a previous study that the c.109G>A mutation allele may be associated with mild-to-moderate hearing impairment (Snoeckx et al., 2005) .
SLC26A4 is another gene whose pathogenic mutations are responsible for congenital deafness worldwide. It encodes pendrin, a 780-amino acid protein that functions as a transmembrane anion exchanger. The most commonly reported mutation alleles of this gene are c.1246A>C and c.1001+1G>A in Northern Europe (Campbell et al., 2001) , versus c.2168A>G and c.919-2A>G in South Korea (Park et al., 2005) and c.2168A>G in Japan (Tsukamoto et al., 2003) . In Japanese and Korean populations, the frequencies of c.2168A>G were 4.1% and 10.34% , respectively. In the Chinese NSHL population with moderateto-profound hearing impairment, the top three common mutations of SLC26A4 are c.919-2A>G at a frequency of 8.01% (377/4704), c.2168A>G at a frequency of 1.51% (71/4704), and c.1174A>T at a frequency of 0.28% (13/4704) (Yuan et al., 2012) .
In the present study, we also found the most common mutation allele of SLC26A4 in the cohort was c.919-2A>G, with the frequency of 6.92%, which was consistent with the nationwide study (Yuan et al., 2012 ) (P-value 2-tail = 0.25). And the frequency of c.2168A>G (0.75%) also showed no difference from the nationwide study (Yuan et al., 2012 ) (Pvalue 2-tail = 0.07). However, in our screening, the frequency of c.1174A>T (0.93%) had moved up one place in the ranking and markedly higher than the one counted in the nationwide study (Yuan et al., 2012 ) (P-value 2-tail < 0.01). It suggested that the c.1174A>T mutation allele, which leads to the substitution of a single amino acid from amides (asparagine) to aromatic species (tyrosine), may be related to more serious conditions of the deafness.
In China, the most common mutation allele of mtDNA12SrRNA is m.1555A>G, which was reported at a frequency of 3.43% (63/1836) (Liu et al., 2006) . However, in the present study, we found a markedly lower frequency of 1.12% (6/535) (P-value 2-tail < 0.01). It was reported that patients with mutations in mtDNA12SrRNA were genetically predisposed to aminoglycoside antibiotic-induced deafness (O'Sullivan et al., 2015) . Yet the clinical application of ototoxic drugs has been strictly controlled for recent years. The patients who had suffered antibiotic-induced deafness long before were too old to receive the cochlear implantation, and they could not be recruited in this study. We inferred this may be one reason for the relatively lower frequency of mutations of mtDNA12SrRNA in the present work. The other reason could be the restriction of ototoxic drugs application at present.
The present study has some limitations. We have not collected the information about deaf probands in the families of participants, and the mutations screened here were restricted to the GJB2, SLC26A4, and mtDNA12SrRNA genes. As far as the profound NSHL population is concerned, the frequencies of mutations in other deafness-causing genes such as GJB3 are also necessary to be detected in future work.
A large number of genes and mutations have been associated with deafness. The present study confirmed that c.235delC of GJB2 and c.919-2A>G (IVS7-2A>G) of SLC26A4 are hot-spot mutations in the Chinese NSHL population. Compared with previous studies, we found that the c.109G>A mutation allele of GJB2 was relatively lower in the profound NSHL population in comparison to the moderate-to-profound ones, and the c.1174A>T mutation allele of SLC26A4 was relatively higher. It suggests that those mutations may be connected with the degree of deafness, which needs more observations and analyses to support.
